a public good project by the
Synthesis
Company
of California

© 2026

Frank S. Lieberman | doi.page

0 works0 citations0 h-index

Frank S. Lieberman

University of Pittsburgh(US)UPMC Hillman Cancer Center(US)University of Pittsburgh Medical Center(US)

Publications by Year

Research Areas

Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune cells in cancer, Brain Metastases and Treatment

Most-Cited Works

→ Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma(2017)2,494 cited
→ Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma(2015)1,203 cited
→ Induction of CD8+T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma(2010)559 cited
→ Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08(2006)431 cited
→ Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas(2008)419 cited
→

Diagnosis, Management, and Evaluation of Chemotherapy-Induced Peripheral Neuropathy

(2006)

411 cited

→ Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors(2012)338 cited

→ Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01(2005)249 cited

→ Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study(2011)221 cited